Cargando…

Hypofractionation and Stereotactic Body Radiation Therapy in Inoperable Locally Advanced Non-small Cell Lung Cancer

BACKGROUND AND AIM: Radiotherapy (RT) plays a key role in the control of locally advanced non-small cell lung cancer (LA-NSCLC). Throughout the years, different doses and fractionations of RT have been used in an attempt to optimize the results. Recently, special interest has been given to hypofract...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rico, Mikel, Martínez, Maribel, Rodríguez, Maitane, Rosas, Lombardo, Barco, Andrea, Martínez, Enrique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Whioce Publishing Pte. Ltd. 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177839/ https://www.ncbi.nlm.nih.gov/pubmed/34104822

Ejemplares similares

Innovative Hypofractionated Stereotactic Regimen Achieves Excellent Local Control with No Radiation Necrosis: Promising Results in the Management of Patients with Small Recurrent Inoperable GBM
por: Jia, Angela, et al.
Publicado: (2016)

Normal tissue toxicity after small field hypofractionated stereotactic body radiation
por: Milano, Michael T, et al.
Publicado: (2008)

Low Incidence of Fatigue after Hypofractionated Stereotactic Body Radiation Therapy for Localized Prostate Cancer
por: Dash, Chiranjeev, et al.
Publicado: (2012)

Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy
por: Kelley, K. D., et al.
Publicado: (2015)

Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy
por: Yamazaki, Hideya, et al.
Publicado: (2011)

Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
por: Ju, Andrew W, et al.
Publicado: (2013)

Prognostic role of stereotactic body radiation therapy for elderly patients with advanced and medically inoperable pancreatic cancer
por: Zhu, Xiaofei, et al.
Publicado: (2017)

Hypofractionated Palliative Radiotherapy in Locally Advanced Inoperable Head and Neck Cancer: CMC Vellore Experience
por: Das, Saikat, et al.
Publicado: (2013)

Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the treatment of inoperable non-small cell lung cancer
por: Amini, Arya, et al.
Publicado: (2012)

Stereotactic body radiation therapy for medically inoperable, clinically localized, urothelial carcinoma of the renal pelvis: A case report
por: Evans, Jaden D., et al.
Publicado: (2017)

Vestibular Schwannoma: Results of Hypofractionated Stereotactic Radiation Therapy
por: Pialat, Pierre-Marie, et al.
Publicado: (2021)

Stereotactic body radiation therapy for palliative management of pancreatic adenocarcinoma in elderly and medically inoperable patients
por: Ryan, John F., et al.
Publicado: (2018)

Impact of tumor size on outcome after stereotactic body radiation therapy for inoperable hepatocellular carcinoma
por: Kuo, Hsing-Tao, et al.
Publicado: (2017)

Magnetic Resonance Imaging-Guided Stereotactic Body Radiation Therapy for Medically Inoperable Endometrial Cancer
por: Dincer, Neris, et al.
Publicado: (2023)

Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer
por: Faria, Sergio L, et al.
Publicado: (2006)

Hypofractionated radiotherapy for medically inoperable stage I non‐small cell lung cancer
por: Jiang, Wei, et al.
Publicado: (2015)

Influence of the Hypersensitivity to Low Dose Phenomenon on the Tumor Response to Hypofractionated Stereotactic Body Radiation Therapy
por: Le Reun, Eymeric, et al.
Publicado: (2023)

Phase I/II Study of Extreme Hypofractionated Stereotactic Body Radiation Therapy Boost to Prostate for Locally Advanced, Node-Positive and Oligometastatic Cancer
por: Narang, Kushal, et al.
Publicado: (2020)

AB013. Treatment of thymic oligometastastic or oligoprogressive lesions with hypofractionated radiation therapy or stereotactic body radiation therapy
por: Jackson, Christopher B., et al.
Publicado: (2022)

Risk‐adapted stereotactic body radiation therapy for central and ultra‐central early‐stage inoperable non‐small cell lung cancer
por: Meng, Mao‐Bin, et al.
Publicado: (2019)

Radiosensitizing Chemotherapy (Irinotecan) with Stereotactic Body Radiation Therapy for the Treatment of Inoperable Liver and/or Lung Metastases of Colorectal Cancer
por: Vaugier, Loïg, et al.
Publicado: (2021)

Rationale for Combing Stereotactic Body Radiation Therapy with Immune Checkpoint Inhibitors in Medically Inoperable Early-Stage Non-Small Cell Lung Cancer
por: Chi, Alexander, et al.
Publicado: (2022)

Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience
por: Ciammella, Patrizia, et al.
Publicado: (2013)

Evaluation of efficacy and safety of robotic stereotactic body radiosurgery and hypofractionated stereotactic radiotherapy for vertebral metastases
por: Księżniak-Baran, Dorota, et al.
Publicado: (2015)

Outcome and toxicity of stereotactic body radiotherapy with helical tomotherapy for inoperable lung tumor: analysis of Grade 5 radiation pneumonitis
por: Aibe, Norihiro, et al.
Publicado: (2014)

Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adaptation
por: Hassanzadeh, Comron, et al.
Publicado: (2020)

Hypofractionated stereotactic body radiotherapy in low- and intermediate-risk prostate carcinoma
por: Kim, Hun Jung, et al.
Publicado: (2016)

Magnetic Resonance-Guided Stereotactic Body Radiation Therapy/Hypofractionated Radiation therapy for Metastatic and Primary Central and Ultracentral Lung Lesions
por: Sandoval, Maria L., et al.
Publicado: (2023)

Cost-utility of stereotactic radiation therapy versus proton beam therapy for inoperable advanced hepatocellular carcinoma
por: Leung, Henry W.C., et al.
Publicado: (2017)

Long-term outcomes of stereotactic body radiation therapy (SBRT) with fiducial tracking for inoperable stage I non-small cell lung cancer (NSCLC)
por: Lischalk, Jonathan W., et al.
Publicado: (2016)

Stereotactic body radiation therapy for locally advanced pancreatic cancer
por: Jung, Jinhong, et al.
Publicado: (2019)

Hypofractionated three-dimensional conformal radiotherapy for medically inoperable early stage non-small-cell lung cancer
por: Lee, Joo Ho, et al.
Publicado: (2013)

Short term clinical outcomes of accelerated hypofractionated radiotherapy in inoperable non-small cell lung cancer patients
por: Aye, Shoon Mya, et al.
Publicado: (2021)

High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma
por: Jang, Won Il, et al.
Publicado: (2013)

Stereotactic Body Radiotherapy for Inoperable Liver Tumors: Results of a Single Institutional Experience
por: Hijazi, Hussam, et al.
Publicado: (2016)

Dosimetric feasibility of stereotactic body radiation therapy as an alternative to brachytherapy for definitive treatment of medically inoperable early stage endometrial cancer
por: Jones, Ryan, et al.
Publicado: (2014)

Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma
por: Moore, Assaf, et al.
Publicado: (2017)

Stereotactic Body Radiation Therapy for Biopsy-Proven Primary Non–Small-Cell Lung Cancer: Experience of Patients With Inoperable Cancer at a Single Brazilian Institution
por: Abreu, Carlos E.C.V., et al.
Publicado: (2018)

Survival Outcomes of Patients Treated with Hypofractionated Stereotactic Body Radiation Therapy for Parotid Gland Tumors: a Retrospective Analysis
por: Karam, Sana D., et al.
Publicado: (2012)

Adjuvant treatment of meningioma with stereotactic radiation surgery and hypofractionated stereotactic radiation surgery: Patterns of care and survival in a large, hospital database
por: Albert, Ashley, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9pk5me5b3r8am60ipum363u1of